A gain-scheduled PID controller for propofol dosing in anesthesia by Padula, F et al.
A gain-scheduled PID controller for
propofol dosing in anesthesia
F. Padula ∗ C. Ionescu ∗∗ N. Latronico ∗∗∗ M. Paltenghi ∗∗∗∗
A. Visioli ‡ G. Vivacqua ‡
∗Department of Information Engineering, University of Brescia, Italy
(e-mail: fabrizio.padula@unibs.it)
∗∗Department of Electrical energy, Systems and Automation, Ghent
University, Belgium (e-mail: ClaraMihaela.Ionescu@UGent.be)
∗∗∗Department of Surgery, Radiology, and Public Health, University of
Brescia, Italy (e-mail: nicola.latronico@unibs.it)
∗∗∗∗ Spedali Civili di Brescia, Italy (e-mail: maxpaltenghi@gmail.com)
†Department of Mechanical and Industrial Engineering, University of
Brescia, Italy (e-mail: antonio.visioli@unibs.it)
‡Department of Mechanical and Industrial Engineering, University of
Brescia, Italy (e-mail: g.vivacqua@studenti.unibs.it)
Abstract: A gain-scheduled proportional-integral-derivative controller is proposed for the
closed-loop dosing of propofol in anesthesia (with the bispectral index as a controlled variable).
In particular, it is shown that a different tuning of the parameters should be used during the
infusion and maintenance phases. Further, the role of the noise filter is investigated.
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1. INTRODUCTION
The closed-loop control of drug dosing has been the sub-
ject of a significant research effort during the last years
especially related to the surgery field, where an adequate
anesthetic state has to be provided to the patient (Mortier
et al., 1998; De Smet et al., 2007; Nogueira et al., 2014).
In principle, having a closed-loop automatic control of
anesthesia might yield different benefits such as an in-
creased safety, a reduced amount of drug used (so that the
post operative recovery time of the patient is reduced) and
a reduced workload for the anesthesiologist (who has in
any case to supervise the overall surgery) (Bibian, 2006).
Actually, in general surgery, anesthesia can be classified
into three functional components, that is, hypnosis, anal-
gesia and immobility, and each component has its own
drug to regulate it.
In this paper we focus on total intravenous anesthesia
(TIVA) and, in particular, on the control of the depth
of hypnosis (DoH) by means of propofol. The controlled
variable is the bispectral index scale (BIS, Aspect Medical
Systems, Norwood, USA), which measures the brain activ-
ity based on a bispectral analysis of the EEG of the patient
(note that an alternative, similar measure is provided by
the wavelet-based index (WAVCNS)).
During the surgery, three phases normally occur. At the
beginning there is the induction phase when the patient is
transitioned from consciousness to the required hypnotic
state. From the control engineering viewpoint, this is a
set-point following task that has to be performed as fast
as possible without a significant overshoot which might
result in a possibly dangerous hypotension (Lindholm
et al., 2009). Then, the required hypnotic level has to
be kept during the maintenance phase, where the task of
the controller is to reject disturbances typically related
to noxious stimuli. Finally, in the emergence phase the
patient is recovered from the anesthesia by stopping the
administration of the drugs.
It appears that the controller has to deal with differ-
ent tasks. The process is usually modelled by using
pharmacokinetic-pharmacodynamic models of the effect of
propofol on the DoH. A linear time invariant model de-
scribes the relation between the propofol infusion rate and
the plasma concentrations, while a nonlinear Hill function
describes the relation between the plasma concentrations
and the clinical effect. In this context, a large interpatient
variability, that is, a large model uncertainty, has to be
considered in the controller design.
In this context, different control strategies have been pro-
posed in the literature. The first option is surely the well-
known proportional-integral-derivative (PID) controller,
which is the most adopted controller in industry owing
to its capability to provide a good performance for a wide
range of processes despite its simplicity. In fact, a PID
controller has been proposed in (Yelneedi et al., 2009) but
the tuning methodology has not been defined precisely.
In (Dumont et al., 2009), the tuning procedure proposed
in (Panagopoulos et al., 2002) is applied to a linearized
model of the system (around the operating point) to
achieve a satisfactory response to disturbances. Although
a two-degree-of-freedom controller is used to handle the
induction phase without overshoot, it has to be noted that
the same PID parameters are used both in the induction
and in the maintenance phases (that is, both for the set-
point following and load disturbance rejection tasks). The
same PID parameters (selected by a trial-and-error proce-
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dure) for both tasks are also employed in (Hahna et al.,
2012). A tuning procedure for the robust load integrated
error minimization is used in (Soltesz et al., 2013) (the
induction phase is controlled in open-loop or manually and
the data collected in this phase are employed to identify
the patient’s model). Also in this case a linearized model is
used for the tuning purpose. Finally, in (van Heusden et al.,
2014) a robust design is proposed for the PID controller,
again by exploiting a linearized model of the system.
Aiming at improving the PID controller performance,
other methodologies have been proposed, such as model
predictive control (Ionescu et al., 2008; Yelneedi et al.,
2009), fractional control (Dumont et al., 2009) and µ-
synthesis (Hahna et al., 2012).
Even if these methodologies are claimed to perform better
than PID controllers, in this paper we propose a new de-
sign methodology for PID controllers, aiming at improving
their performance and therefore to provide a benchmark
for a fair comparison with other methodologies. In par-
ticular, differently from the approaches already proposed
in the literature related to propofol dosing, the following
issues are considered: (i) the PID parameters are selected
separately for the induction and the maintenance phases,
yielding a gain scheduled controller; (ii) the PID parame-
ters are selected by considering a worst-case optimization
on a set of patients in order to guarantee in any case that
the approach is safe; (iii) the PID parameters are selected
by considering explicitly the (static) nonlinearity of the
process. Further, the role of the noise filter is investigated
by analyzing the loss of performance that might occur in
order to avoid an excessive actuator excitation. In order
to pursue these objectives, a genetic algorithm is employed
by considering a population of 12 patients (Ionescu et al.,
2008). Even if the considered set can be seen as rep-
resentative of a large population as very different kinds
of patients are included, it cannot be claimed that it is
exhaustive. However, the set is sufficient for the aim of
the presented investigation, that is, showing that it is
necessary to carefully consider the PID controller tuning
before concluding that another controller provides a better
performance.
2. PHARMACOKINETIC-PHARMACODYNAMIC
MODEL
The overall effect of the propofol drug infused in the hu-
man body can be then modelled by considering the linear
dynamics of its pharmacokinetics and pharmacodynamics
in series with a static nonlinear function (Ionescu et al.,
2008). Pharmacokinetics is usually described by means of a
third-order transfer function PK(s) with two zeros, where
the parameters of the model can be obtained as suggested
in (Schnider et al., 1998), where they depend on age,
weight, height and sex of the patient. Pharmacodynamics
is characterized by a first-order delay-free transfer function
PD(s) whose parameters depend on the metabolism of
the drug and it is therefore independent from the patient
(Schnider et al., 1998).
Then, the relation between plasma drug concentration Ce
and clinical effect can be mathematically expressed by
the means of a nonlinear sigmoid function, known also
as Hill function, which models the bispectral index scale
(BIS), a dimensionless parameter normalized between 0
and 100, indicating isoline EEG and fully awake patient
respectively:
BIS(t) = E0 − Emax
(
Ce(t)
γ
Ce(t)γ + C
γ
e50
)
, (1)
where E0 is the baseline value representing the initial
infusion-free state of the patient, Emax is the maximum
reachable effect achieved by the infusion, γ denotes the
slope of the curve (i.e., the receptiveness of the patient to
the drug) and Ce50 is the necessary concentration of the
drug to reach the half maximal effect.
It is worth stressing that the Hill function is highly non-
linear. In fact, at the beginning of the infusion, the curve
presents a plateau, where the presence of little quantities
of the drug in the effect compartment does not affect the
clinical effect until the drug concentration reaches a certain
value. The final saturation expresses the impossibility to
overcome the maximum achievable value Emax regardless
of the amount of hypnotic infused.
In order to take into account the intrapatient variability,
the dataset of patients presented in (Ionescu et al., 2008)
has been employed. In addition to the set of 12 patients,
a thirteenth individual has been considered as the average
patient of the group, calculating for each available parame-
ter its algebraic mean. The values of the model parameters
for the considered population are presented in Table 1.
Id Age H [cm] W [kg] Gender Ce50 γ E0 Emax
1 40 163 54 F 6.33 2.24 98.8 94.10
2 36 163 50 F 6.76 4.29 98.6 86.00
3 28 164 52 F 8.44 4.10 91.2 80.70
4 50 163 83 F 6.44 2.18 95.9 102.00
5 28 164 60 M 4.93 2.46 94.7 85.30
6 43 163 59 F 12.00 2.42 90.2 147.00
7 37 187 75 M 8.02 2.10 92.0 104.00
8 38 174 80 F 6.56 4.12 95.5 76.40
9 41 170 70 F 6.15 6.89 89.2 63.80
10 37 167 58 F 13.70 1.65 83.1 151.00
11 42 179 78 M 4.82 1.85 91.8 77.90
12 34 172 58 F 4.95 1.84 96.2 90.80
13 38 169 65 F 7.42 3.00 93.1 96.58
Table 1. Characteristic variables for the con-
sidered set of patients (H: height, W: weight).
3. OPTIMAL TUNING OF PID CONTROLLERS
3.1 Control scheme
The employed control scheme is the standard feedback
scheme shown in Figure 1 where the feedback controller
is a PID controller whose transfer function is
C(s) = Kp
(
1 +
1
sTi
+ sTd
)
1
(Tfs+ 1)2
(2)
where Kp is the proportional gain, Ti is the integral time
constant, Td is the derivative time constant and Tf is the
time constant of a second-order filter for the measurement
noise (note that the use of a second-order filter is the
most suitable solution as shown in (Segovia et al., 2014)).
A standard anti-windup back calculation method (Soltesz
et al., 2013) has also been implemented even if this issue
is not critical for the provided tuning (see Section 3.2).
The control tasks are initially to track the set-point step
signal r from the initial BIS value of the patient to a
final value equal to 50 during the induction phase and
then to reject the disturbances during the maintenance
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C(s)- PD(s)
Noise
Hill Function
Disturbance
PK(s)
r(t) e(t) u(t) BIS(t)
Fig. 1. The considered control scheme.
phase. Even if different disturbance patterns have been
proposed in the literature for the controller evaluation
(Struys et al., 2004; Dumont et al., 2009) here the one
used in (Soltesz, 2013) has been considered as it allows
an easy characterization of the control performance. It
consists of a step signal of amplitude 10, acting directly
on the process variable, followed by another step after
20 minutes of amplitude -10. Finally, measurement noise
has been added to the feedback signal. This issue will be
analyzed in Section 3.3.
3.2 Optimal PID tuning
The optimal PID parameters have been determined by
employing a genetic algorithm (Mitchell, 1998) in order
to minimize the integrated absolute error defined as
IAE =
∫
|e(t)|dt (3)
in the worst case when all the patients are considered (see
Table 1). Note that the set-point following and disturbance
rejection have been considered separately. The IAE index
has been selected as it considers a fast response without a
significant overshoot at the same time. Further, in each
case, two different limits for the control variable has
been set, that is, 4.00 [mg/s] and 6.67 [mg/s]. The first
saturation upper limit has been chosen by considering the
usual clinical practice, while the second value has been
chosen by taking into account the maximum rate of a
standard medical pump and the concentration of propofol
hypnotic drug.
Initially, the noise-free case has been considered. Results
obtained by the genetic algorithm optimization are shown
in Table 2 and in Figure 2 where the control variable is
normalized with respect to the weight of the patient. It can
be noticed that the tuning in case of disturbance rejection
is more aggressive than the case of set-point following, as
the proportional gain is bigger and the derivative time
constant is smaller.
Case Max rate [mg/s] Worst-case IAE Total infusion [mg] Kp Ti Td Tf
Dist 4.00 1621.14 538.50 0.1055 889.3581 18.7711 0.8159
Dist 6.67 1659.34 538.43 0.0916 903.0916 14.9617 0.9092
SP 4.00 3374.55 239.92 0.0653 497.3168 36.2344 0.0476
SP 6.67 3278.65 241.65 0.0660 445.6125 39.9799 0.4310
Table 2. Optimal PID parameters for IAE min-
imization criteria (disturbance rejection and
set-point following task). IAE and total infu-
sion are calculated for the worst patient re-
sponse among the set of patients.
3.3 Noise filter tuning
In the real application, the noise level of the BIS signal
is very significant and this implies that a great attention
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Fig. 2. Simulated patients response to propofol infusion.
PID controller tuned for set-point following task
(top), for disturbance rejection task (bottom). Maxi-
mum infusion rate of 4.00 [mg/s] (blue), or maximum
infusion rate of 6.67 [mg/s] (red).
should be paid in tuning the (second-order) filter time
constant. For this purpose, a simple method to tune the
Tf parameter is then proposed.
• The set-point following and disturbance rejection
tasks are considered as two separated case studies for
the tuning procedure. Noise is introduced through an
additive white Gaussian block with zero mean value
and a standard deviation equal to σ = 6.2721; this
latter value has been obtained from real BIS data.
The PID parameters Kp, Ti, Td have been set as they
have been found from the noise-free optimization.
• The Tf time constant has been varied in a selected
range, whose upper and lower limits are defined on the
basis of the Tf values obtained in the corresponding
tests without measurement noise.
• For each value of Tf , combined with the other PID
parameters, the infusion response is calculated for all
the patients in the considered set. If the minimum BIS
value of a single patient response reaches a predefined
undershoot threshold value, i.e., falls below 25, the
test is discarded and Tf is incremented.
• The calculated IAE indices are compared with the
worst-case IAE obtained in the corresponding noise-
free tests; the comparison is obtained through a
performance decay ratio index defined as:
dk =
IAEnoise,k − IAEworst
IAEworst
, (4)
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where IAEnoise,k indicates the integrated absolute
error value obtained with the selected Tf for the
kth patient, and IAEworst denotes the same index
calculated for the worst response in the noise-free case
and with the optimal output-filtered PID parameters
determined by the genetic algorithm.
• For each iteration the filtering time constant Tf and
the biggest decay among the patients are correlated;
the correlation is not unique, considering that dif-
ferent Tf parameters can induce the same effect in
percentage. In addition, not all the filter time con-
stants lead to an evaluation because of the consid-
ered threshold undershoot condition, which limits the
range of the possible selectable parameters.
The performance decay trends for the tuned time filtering
Tf constants are presented in Figure 3. Black circles denote
the filter time constants calculated for the noise-free cases,
red and green stars indicate the lower and upper values
of the filter parameters which induce respectively a 20%
and 30% decay of the performance. Only the case with a
maximum pump rate of 6.67 [mg/s] is shown for the sake
of brevity, but results related to the other case are very
similar.
This particular trend is obtained because:
• for low Tf values, filtering is not effective. Thus, mea-
surement noise enters without almost any filtering in
the controller, and it is amplified by the derivative
action. Then, taking into account that noise is also
zero mean, the main problem is the saturation block:
indeed, the control variable normally operates closer
to the lower saturation limit, hence noise is saturated
asymmetrically. The process variable fluctuation in-
duced by the noise presence can be easily managed
by the positive actuator reaction, but when the vari-
ation forces the BIS index to decrease, the control
variable cannot counteract, but only saturates to the
zero lower saturation limit. High-frequency zero mean
noise thus becomes high-frequency noise with non-
zero mean. In other words, the additive input is seen
as a bias the controller tries to compensate, chang-
ing the overall closed-loop dynamics, and perturbing
the expected modelled behaviour. With a different
dynamics the new IAE index calculated differs a lot
from that obtained with the same parameters in the
noise-free case, explaining the exponential decrease of
the performance;
• for high Tf values, a significant dynamics is intro-
duced in the overall system. Hence, the increasing
difference between the output obtained in the noise-
free simulation and the output in presence of measure-
ment noise is due to the distortion the new dynamics
induces;
• there exist particular Tf values which assure a fair
noise filtering and at the same time preserve the decay
of the performance. By setting the tuning parameter
within these bounds, it is possible to realize a virtual
tuning knob, that is, the tuning of the filter time
constant can be done by imposing a tolerated de-
cay for the infusion profile. Reasonable performance
decay indices are between the 20% and 30%, which
correspond to a balanced trade-off between the noise
filtering and the optimal regulation. Furthermore, the
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Fig. 3. Simulated performance decay ratio over the filtering
time constant Tf for set-point following (top) and
disturbance rejection (bottom). Maximum pump rate
of 6.67 [mg/s]. Red stars: Tf parameters which lead
to a decrease of 20% of IAE. Green stars: decrease of
30%. Black circle: noise-free optimal Tf parameter.
concavity present in the curve offers the possibility to
reach the same result with two different parameters.
Obviously, the greatest between the two should be
chosen in order to achieve a strongest noise reduction
effect.
The results of the patients response in the presence of
noise are shown in Figure 4. The blue lines represent the
results of the noise-free simulations. The red and green
lines denote the results in presence of the measurement
noise where the filtering time constant Tf has been chosen
to assure a maximum decay performance ratio respectively
of 20% and 30%.
It can be noticed that the control variable resulting from
the simulations is still noisy and it presents strong high-
frequency variations due to the noise action. As previously
mentioned, a trade-off between the noise reduction and
the introduction of an additional dynamics exists. It is
therefore interesting to evaluate also the performance that
can be obtained by considering a PI controller without the
derivative action.
3.4 Optimal PI tuning
The same procedure employed for PID controllers has been
then applied to PI controllers (that is, by setting Td = 0
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Fig. 4. Simulated patients response for set-point following
(top) and disturbance rejection (bottom). Maximum
pump rate of 6.67 [mg/s]. Responses in absence of
noise (blue), and in presence of noise with a filtering
action which leads to a maximum decay performance
ratio of 20% (red) and 30% (green).
Case Max rate [mg/s] Worst-case IAE Total infusion [mg] Kp Ti Tf
Dist 4.00 1877.03 538.50 0.0795 906.4321 0.0107
Dist 6.67 1848.23 538.53 0.1088 1288.4393 0.0110
SP 4.00 5839.82 230.21 0.0329 482.6038 0.0161
SP 6.67 5756.36 232.21 0.0315 400.0012 0.0117
Table 3. Optimal PI parameters for IAE min-
imization criteria (disturbance rejection and
set-point following task). IAE and total infu-
sion are calculated for the worst patient re-
sponse among the set of patients.
in (2)). The optimal tuning resulting in the noise-free case
are shown in Table 3 and in Figures 5. It appears the
significant difference in the (optimal worst-case) tuning
related to the set-point following and disturbance rejection
tasks.
Regarding the tuning of Tf , considerations similar to the
PID case can be done also in this case (results are not
shown for the sake of brevity).
4. GAIN SCHEDULING APPROACH
The difference found during the optimal tuning for set-
point following and disturbance rejection tasks suggests a
gain scheduling technique. In particular, the PI(D) con-
troller tuned for the set-point following task is employed
only during the induction phase of anesthesia. Then, when
the target is attained and the DoH is stabilized around
the target for a predefined time interval, the controller
Fig. 5. Simulated patients response to propofol infusion.
PI controller tuned for set-point following task (top),
for disturbance rejection task (bottom). Maximum
infusion rate of 4.00 [mg/s] (blue), or maximum
infusion rate of 6.67 [mg/s] (red).
Task Max rate [mg/s] Worst-case IAE for dist Worst-case IAE for SP Decay [%]
Dist 4.00 1877 2210 17.78
Dist 6.67 1848 2110 14.19
SP 4.00 7580 5839 29.81
SP 6.67 8477 5756 47.28
Table 4. Integral absolute error decay calcu-
lated inverting the optimal parameters for a
specific task.
parameters are switched to the disturbance rejection op-
timal ones (note that a bumpless switching has to be
implemented).
In order to highlight the need of the gain-scheduled PI(D)
controller, the responses of the patients when the tuning
for the set-point tracking task is used for disturbance rejec-
tion and vice versa are shown in Figure 6 (a PI controller
for the 6.67 [mg/s] case is considered as example). It is
especially evident that, in the induction phase, the tuning
devised for the load disturbance causes in some cases a long
time interval where the control variable saturates and this
yields an oscillatory behaviour and a possibly dangerous
excessive overshoot.
The decay of performance calculated for the worst case
among the patients set, inverting the optimal parameters
of the specific tasks are shown in Table 4, confirming the
effectiveness of the gain scheduling technique.
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Fig. 6. Simulated patients response to propofol infusion
for set-point following (top) and disturbance rejection
(bottom) tasks. Maximum pump rate of 4.00 [mg/s].
Optimal set-point tuning (red), and optimal distur-
bance tuning (blue).
5. CONCLUSIONS
In this paper we have proposed a gain scheduling approach
for the tuning of PID controllers for propofol dosing in
anesthesia. In particular, we have shown that, if the PID
parameters are optimally tuned by minimizing the worst-
case integrated absolute error in the response of a given
set of patients, it is worth considering the induction phase
separately from the maintenance phase. Further, the noise
filter time constant selection should be carefully done. It
is worth noting that, even if the considered set of patients
is obviously not exhaustive (although representative) of
the overall population, it is sufficient to demonstrate the
main concepts. It is therefore believed that advanced
control strategies for anesthesia should be compared with
optimally tuned PID controllers, where the control tasks
are considered separately, the nonlinear model is explicitly
taken into account, and the additional functionalities such
as noise filter, anti-windup and so on are implemented.
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